No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

Although a federal judge has temporarily blocked the policy change, government grants to early-stage biotech startups could still face delays or be eliminated entirely, said Chris Gibson ...

“These investments have borne fruit. For example, our biotech ecosystem would not be where it is today without Biopolis, which we built more than 20 years ago,” he said. Within the biotech and ...

Lati­go Bio­ther­a­peu­tics, a non-opi­oid pain biotech look­ing to ride the waves cre­at­ed by Ver­tex Phar­ma­ceu­ti­cals’ pain drug ap­proval last month, is tar­get­ing up to … ...

Now, the pharma giant claims to have been misled by the biotech’s founder—and a judge seems to agree. Novo Nordisk wants its money back from a biotech called KBP Biosciences that sold a hypertension ...

Michael is so brilliant in the way that he works. And he never ceases to amaze me. I’ve watched him in so many facets of business, in science and biotech, in philanthropy, and like somehow, he’s also ...

The biotech industry is under legal fire. While 2024 has been a year of resilience in terms of performance for the industry, there’s been a sharp increase in the number of class action lawsuits ...

The Swedish biotech behind a groundbreaking Alzheimer’s treatment is in talks with partners for its new technology that allows drugs to cross the notoriously tricky blood-brain barrier.

Boston biotech Kojin Therapeutics is closing its doors, citing four funding challenges and a few valuable lessons learned. The cancer- and autoimmune-focused company will wind down operations over ...

The Boston biotech’s series A follows a $15 million seed financing that closed in September 2024. That round was co-led by BVF Partners and KKR’s Dawn Biopharma, with participation from Salvia ...

Bio-Rad Laboratories, a Bay Area biotech giant best known for its diagnostic and research products, is laying off 5% of its staff — including more than 100 workers from its headquarters in Hercules.